BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. Comprising 15 amino acids, BPC-157 has been the subject of extensive preclinical investigation across multiple tissue repair contexts, including musculoskeletal injury, gastrointestinal mucosal healing, tendon regeneration, and wound repair. Its stability in gastric acid and ability to remain active in various biological environments has made it a useful tool compound in laboratory research settings.
Mechanism of Action
BPC-157 research has focused on several proposed molecular mechanisms. Preclinical studies suggest BPC-157 modulates the nitric oxide (NO) system, influencing vascular tone and angiogenesis in injured tissue. Additional research has examined its interaction with growth hormone receptor signaling pathways, particularly in the context of tendon and muscle repair models.
In vitro studies have demonstrated BPC-157 effects on fibroblast migration and proliferation — cellular processes central to connective tissue repair. Animal model research has also examined its influence on VEGF (vascular endothelial growth factor) expression, a key mediator of angiogenesis during tissue healing.
Preclinical Research Applications
- Musculoskeletal research: Rodent models have examined BPC-157 effects on muscle crush injuries, ligament transections, and bone repair. Studies have investigated cellular markers of repair including collagen synthesis and fibroblast activity (Sikiric P, et al., 2018, Current Pharmaceutical Design).
- Gastrointestinal research: BPC-157 was originally identified in the context of gastric mucosal protection. Preclinical models have examined its effects on intestinal anastomosis healing, inflammatory bowel models, and esophageal injury repair.
- Tendon and ligament research: In vitro and rodent studies have investigated BPC-157 effects on tendon fibroblast outgrowth and Achilles tendon transection models, examining cellular markers of tendon regeneration.
- Wound healing models: Cutaneous wound healing studies in rodent models have examined BPC-157 effects on wound closure rates, collagen deposition, and inflammatory cell recruitment.
Research Considerations
BPC-157 research remains primarily in preclinical stages. The majority of published studies have been conducted in rodent models under controlled laboratory conditions. As with all research peptides, findings from animal models require rigorous validation before conclusions can be drawn about biological mechanisms in other systems.
All research use of BPC-157 should be conducted in accordance with applicable institutional protocols and regulatory guidelines. This compound is intended solely for laboratory and academic research applications.
Selected References
- Sikiric P, et al. “Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract.” Current Pharmaceutical Design. 2018;24(18):1990–2001.
- Chang CH, et al. “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.” Journal of Applied Physiology. 2011;110(3):774–780.
- Gwyer D, et al. “Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.” Cell and Tissue Research. 2019;377(2):153–159.
All content on this blog is intended for educational and research reference purposes only. 303 Peptides supplies research compounds exclusively for laboratory and academic use. Nothing on this site constitutes medical advice or guidance for human use.
